Variant report
Variant | esv3360098 |
---|---|
Chromosome Location | chr1:103491889-103494137 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs200821950 | chr1:103491892-103491893 | Weak transcription Strong transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530565995 | chr1:103491898-103491899 | Weak transcription Strong transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375217785 | chr1:103491923-103491924 | Weak transcription Strong transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs551516124 | chr1:103491951-103491952 | Weak transcription Strong transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs548659290 | chr1:103492018-103492019 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs74606576 | chr1:103492024-103492025 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs528657573 | chr1:103492059-103492060 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs78438559 | chr1:103492077-103492078 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs571816114 | chr1:103492094-103492095 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs78668559 | chr1:103492108-103492109 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs369033129 | chr1:103492111-103492112 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs557349080 | chr1:103492142-103492143 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs192285040 | chr1:103492144-103492145 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528650803 | chr1:103492155-103492156 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536775449 | chr1:103492159-103492160 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs28700094 | chr1:103492163-103492164 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs551516731 | chr1:103492168-103492169 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs67985164 | chr1:103492179-103492180 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs71667600 | chr1:103492182-103492183 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573800622 | chr1:103492189-103492190 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs540831672 | chr1:103492203-103492204 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs201153746 | chr1:103492204-103492205 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553241222 | chr1:103492248-103492249 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs77847487 | chr1:103492268-103492269 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs72683299 | chr1:103492272-103492273 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs143101451 | chr1:103492318-103492319 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530409968 | chr1:103492342-103492343 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs542342585 | chr1:103492358-103492359 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs182893733 | chr1:103492360-103492361 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs76617429 | chr1:103492367-103492368 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs546840872 | chr1:103492375-103492376 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs34583128 | chr1:103492433-103492434 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573152078 | chr1:103492436-103492437 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs557058301 | chr1:103492480-103492481 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs532905686 | chr1:103492514-103492515 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs575314078 | chr1:103492569-103492570 | Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs551289628 | chr1:103492606-103492607 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs373688244 | chr1:103492618-103492619 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs535818311 | chr1:103492619-103492620 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs569299150 | chr1:103492694-103492695 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542888071 | chr1:103492732-103492733 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs536617477 | chr1:103492745-103492746 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs561527513 | chr1:103492825-103492826 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs555060234 | chr1:103492840-103492841 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs573308545 | chr1:103492862-103492863 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs555722616 | chr1:103492864-103492865 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs3934352 | chr1:103492900-103492901 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs534818302 | chr1:103492948-103492949 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs375561451 | chr1:103492953-103492954 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs369742125 | chr1:103492954-103492955 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 22429812 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Autism | 17483303 | CNVD |
Intestinal disease | 21956041 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Schizophrenia | 17879154 | CNVD |
Mental retardation | 17124404 | CNVD |
Intestinal disease | 17828263 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Lung cancer | 17086460 | CNVD |
Gastric cancer | 16891809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:103369600-103498600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr1:103446800-103497800 | Weak transcription | HSMM | muscle |
3 | chr1:103449200-103545200 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr1:103460200-103516400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr1:103475800-103516600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr1:103487000-103492200 | Strong transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr1:103487600-103493600 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr1:103489200-103516400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
9 | chr1:103489600-103506000 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr1:103491200-103492400 | Genic enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr1:103491400-103492000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr1:103491400-103492000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr1:103491600-103492000 | Genic enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr1:103491600-103492000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
15 | chr1:103491600-103503800 | Weak transcription | NH-A | brain |
16 | chr1:103491800-103492600 | Genic enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
17 | chr1:103492000-103496400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
18 | chr1:103492200-103493000 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
19 | chr1:103492400-103497200 | Strong transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
20 | chr1:103492600-103493800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
21 | chr1:103493000-103494000 | Strong transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
22 | chr1:103493800-103495600 | Strong transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
23 | chr1:103494000-103500200 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |